WPD Pharmaceuticals (XCNQ:WBIO) Growth Rank : 0 (As of May. 17, 2024)

View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Growth Rank?

WPD Pharmaceuticals has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

WPD Pharmaceuticals Growth Rank Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals (XCNQ:WBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

750 West Pender Street, Suite 401, Vancouver, BC, CAN, V6C 2T7

Website

https://www.wpdpharmaceuticals.com

WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.

WPD Pharmaceuticals (XCNQ:WBIO) Headlines

No Headlines